Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lobo, Leonard
HALT-IPF, NCT04262167: Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis	Recruiting	1	24	US	Lung Spheroid Stem Cells 100 million, LSCs, Lung Spheroid Stem Cells 200 million	University of North Carolina, Chapel Hill	Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease	03/26	03/27
Hemphill, Caleb
HALT-IPF, NCT04262167: Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis	Recruiting	1	24	US	Lung Spheroid Stem Cells 100 million, LSCs, Lung Spheroid Stem Cells 200 million	University of North Carolina, Chapel Hill	Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease	03/26	03/27
NCT04543461: American Lung Association (ALA) Lung Health Cohort	Recruiting	N/A	4000	US		Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), American Lung Association, Stanford University	Lung Diseases	09/26	09/26
A1BC, NCT05297812: Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease	Active, not recruiting	N/A	286	US		Columbia University, Alpha-1 Foundation, National Heart, Lung, and Blood Institute (NHLBI)	Alpha 1-Antitrypsin Deficiency, Genetic Disease	01/27	01/27
IPF-PRO, NCT01915511: Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry Oct 2015 - Oct 2015:	Recruiting	N/A	3000	US		Duke University, Boehringer Ingelheim	Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease	01/28	01/28